Guidelines for Stability Testing of Highly Potent Drugs

1) Purpose

The purpose of this SOP is to provide a standardized procedure for conducting stability studies on highly potent drugs. These drugs require special handling and storage conditions due to their high pharmacological activity and sensitivity to environmental factors.

2) Scope

This SOP applies to all highly potent drugs produced, handled, or stored by the organization, including cytotoxic drugs, hormonal agents, and immunosuppressants. It is intended for personnel involved in formulation, quality control, and regulatory affairs.

3) Responsibilities

Formulation Scientist: Responsible for designing the stability study protocol and selecting appropriate stability-indicating parameters.

Quality Control (QC) Team: Responsible for conducting stability tests according to the approved protocol and documenting results.

QA Team: Responsible for reviewing data, ensuring regulatory compliance, and approving the final stability report.

4) Procedure

4.1 Study Design:

1. Identify stability-indicating parameters (e.g., potency, purity, content uniformity, and physical appearance) relevant to
   

   “Unlocking the Secrets of Pharmaceutical Preservation: Delving Into the Fascinating Realm of Chemical Stability in Pharmaceuticals!”

   the highly potent drug.
2. Select appropriate analytical methods (e.g., HPLC, spectrophotometry) to evaluate these parameters.
3. Define storage conditions (e.g., controlled room temperature, refrigerated, light protection) based on the product’s characteristics and regulatory guidelines.
4. Develop a detailed study protocol outlining the objectives, sampling schedule, and analytical methods.

4.2 Sample Preparation:

1. Prepare samples from representative production batches and label